Related Experiment Video
Updated: Feb 3, 2026

A Calcium Phosphate-Induced Mouse Abdominal Aortic Aneurysm Model
Published on: November 18, 2022
Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus
Insights
Sevelamer is a cost-effective alternative to calcium carbonate for managing hyperphosphatemia in Malaysian chronic kidney disease (CKD) patients, offering improved life years and quality-adjusted life years (QALYs). This finding supports its use, especially for patients with high calcium loads.
Area of Science:
- Nephrology
- Health Economics
- Pharmacoeconomics
Background:
- Hyperphosphatemia is common in chronic kidney disease (CKD).
- Calcium carbonate (CaCO3) is a common treatment but increases calcium load and cardiovascular risk.
- Non-calcium phosphate binders are alternatives but are more expensive.
Purpose of the Study:
- To analyze the cost-effectiveness of sevelamer versus CaCO3.
- To evaluate treatment for hyperphosphatemia in stage III-V predialysis CKD patients in Malaysia.
Main Methods:
- A Markov decision model simulated a cohort of CKD patients.
- Survival data from the INDEPENDENT-CKD trial was used.
- Malaysian cost data and literature-derived utilities were incorporated.
Main Results:
- Sevelamer yielded 6.37 life years (5.27 QALYs) vs. 4.25 life years (3.54 QALYs) with CaCO3.
- Lifetime costs were higher for sevelamer (RM159,901) than CaCO3 (RM77,139).
- The incremental cost-effectiveness ratio (ICER) for sevelamer was RM47,679 per QALY, below the WHO threshold.
Conclusions:
- Sevelamer is potentially cost-effective compared to CaCO3 for predialysis CKD patients in Malaysia.
- Sevelamer offers improved survival and quality-adjusted life years.
- The study recommends sevelamer as a treatment option, particularly for patients with high calcium loads.
Background:
Hyperphosphatemia in chronic kidney disease (CKD) patients is often treated with calcium carbonate (CaCO3) despite the fact that CaCO3 is associated with increased calcium load and potentially increased cardiovascular risk. Alternative treatments with noncalcium-based phosphate binders do not increase the calcium load but are more costly. This study analyzes the cost-effectiveness of sevelamer versus CaCO3 for the treatment of hyperphosphatemia in stage III-V predialysis CKD patients in Malaysia.
Methods:
A Markov decision model was adapted to simulate a hypothetical cohort of CKD patients requiring treatment for hyperphosphatemia. Survival was estimated by using efficacy data from the INDEPENDENT-CKD clinical trial. Cost data was obtained from Malaysian studies while health state utilities were derived from literature. Analysis was performed over lifetime duration from the perspective of the Ministry of Health Malaysia with 2013 as reference year.
Results:
In the base case analysis, sevelamer treatment gained 6.37 life years (5.27 QALY) compared to 4.25 life years (3.54 QALY) with CaCO3. At 3% discount, lifetime costs were RM159,901 ($48,750) and RM77,139 ($23,518) on sevelamer and CaCO3, respectively. Incremental cost-effectiveness (ICER) of sevelamer versus CaCO3 was RM47,679 ($14,536) per QALY, which is less than the WHO threshold of three times GDP per capita (RM99,395) per QALY. Sensitivity analyses, both using scenario sensitivity analysis and probabilistic sensitivity analysis, showed the result to be robust.
Conclusions:
Our study finds that sevelamer is potentially cost-effective compared to CaCO3, for the treatment of hyperphosphatemia in predialysis CKD III-V. We propose that sevelamer should be an option in the treatment of Malaysian predialysis patients with hyperphosphatemia, particularly those with high calcium load.
Related Concept Videos
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
DNA Base Pairing
Strong Acid and Base Solutions
Pharmacodynamics in Geriatric Patients: Effects of Age
Acids, Bases and Neutralization Reactions
Classification of Titrimetric Analysis Based on Reaction Types
Titrations between an acid and a base lead to neutralization reactions that form...

